Comparison of two parenteral diphosphonates in hypercalcemia of malignancy
- 1 February 1982
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 72 (2), 221-226
- https://doi.org/10.1016/0002-9343(82)90813-0
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Parenteral diphosphonates for treating malignant hypercalcemiaCancer, 1981
- Hypercalcemia of Malignancy: Treatment with Intravenous Dichloromethylene DiphosphonateAnnals of Internal Medicine, 1981
- The effect of prostaglandin synthesis inhibitors and diphosphonates on tumour-mediated osteolysisBritish Journal of Surgery, 1980
- EFFECT OF DICHLOROMETHYLENE DIPHOSPHONATE IN PAGET'S DISEASE OF BONE AND IN HYPERCALCÆMIA DUE TO PRIMARY HYPERPARATHYROIDISM OR MALIGNANT DISEASEThe Lancet, 1980
- Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.Journal of Clinical Investigation, 1980
- Effects of Dichloromethylene Diphosphonate on Skeletal Mobilization of Calcium in Multiple MyelomaNew England Journal of Medicine, 1980
- New Diphosphonates to Block Bone ResorptionNew England Journal of Medicine, 1980
- DiphosphonatesCalcified Tissue International, 1979
- INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- Modifications of a specific assay for hydroxyproline in urineAnalytical Biochemistry, 1967